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The effect of the plant alkaloid ryanodine on the 
skeletal muscle sarcoplasmic reticulum Ca" release 
channel was studied by determining the Ca" permea- 
bility of "heavy"  vesicles passively loaded with 4eCa2+ 
in  the presence or absence of ryanodine. Depending  on 
the  experimental conditions, ryanodine either stimu- 
lated or inhibited Ca2+ efflux. Vesicles were  rendered 
permeable to 4sCa2+ at a ryanodine concentration of 
0.01 PM when diluted into a medium containing the 
two Ca" release channel inhibitors Mg2+ and ruthe- 
nium red. At ryanodine concentrations greater  than 
10 PM, 4eCa2+ efflux was inhibited in channel-activat- 
ing (5 PM Ca") or -inhibiting (10 mM Mg2+ plus 10 PM 
ruthenium red) media. An optimal stimulatory effect 
was observed when  vesicles were incubated with  ry- 
anodine at 37 "C and in media that caused partial open- 
ing of the channel. Similar  results to those described 
above were obtained using cardiac sarcoplasmic retic- 
ulum  vesicles that  were capable of rapid 4sCaa+ efflux. 
Use of the slowly permeating molecule ~-[~H]glucose 
allowed measurement of channel-mediated efflux rates 
from vesicles in  the presence and absence of ryanodine. 
At low activating concentrations, ryanodine did not 
appreciably change the regulation of L-glucose efflux 
rates by external Ca2+,  Mgz+, and adenine nucleotide. 
These results suggested two possible  modes of action 
of ryanodine: 1) a change in the  gating mechanism of 
the channel which is not readily detected using the 
slowly permeating molecule  L-glucose or 2) a change 
in channel structure which prevents its complete  clos- 
ing. 
The sarcoplasmic reticulum (SR1) in muscle is a specialized 
intracellular membrane system which rapidly sequesters and 
releases Ca" (for reviews see Refs. 1-3). Sequestration of the 
released Ca" into SR is mediated by the Ca'+-stimulated 
Mg2+-dependent ATPase or Ca2+ pump. Release of  Ca" from 
SR is triggered by an action potential originating at the 
neuromuscular junction and communicated to SR via an 
extension of the surface membrane, the T-tubule. Although 
the mechanism by which T-tubule depolarization induces Ca2+ 
release from. SR has remained obscure, recent  studies have 
indicated the presence of a ligand-gated SR "Caz+ release 
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channel'' which is activated by Ca" and adenine nucleotides 
and inhibited by Mg2+ (4-13). 
Ryanodine is a neutral  plant alkaloid with profound effects 
on muscle (14). This naturally occurring product, as isolated 
from Ryunia speciosu, is composed of two  major active com- 
ponents, ryanodine and 9,21-didehydroryanodine, in a ratio 
of 1:3  (15, 16). The two components display equal toxicity 
and  bind at nanomolar concentrations  in a Ca2+-dependent 
manner to heavy SR vesicle preparations from skeletal and 
cardiac muscle (17,  18). 
As pointed  out by Jenden  and  Fairhurst (14) and  Sutko et 
al. (19), the effects of ryanodine on muscle are complex and 
depend on muscle type, calcium activity, pattern of muscle 
stimulation,  as well as ryanodine concentration. For example, 
in  vertebrate skeletal muscle, ryanodine produces an irrever- 
sible contraction,  yet  in cardiac muscle a decline in contractile 
force is observed. In isolated SR vesicle fractions, ryanodine 
has been assumed to activate or inhibit a Ca" permeable 
pathway. Cardiac SR contains a subpopulation of vesicles 
which exhibit an increased Caz+-loading activity and Ca2+ 
loading/ATP hydrolysis coupling ratio in the presence of 
ryanodine (20,  21). In a recent study, ryanodine initially 
induced a slight inhibition of oxalate-supported Ca" uptake 
followed  by a later  stimulation of  Ca" uptake (22). In "heavy" 
skeletal muscle SR vesicle preparations, isolated by centrif- 
ugation between 2000 and 8000 X g, ryanodine increased the 
rate of Ca2+ efflux from vesicles which had been actively 
loaded with Ca2+ (23). A more recent study showed that high 
concentrations of ryanodine (300 pM) increased oxalate-sup- 
ported Ca2+ uptake by junctional SR vesicle fractions, presum- 
ably by blocking a Ca2+-permeable pathway (24). By contrast, 
at submicromolar concentrations, ryanodine appeared to lock 
the Ca2+ release channel of SR in an "open state" (18). 
Because most previous studies have utilized actively loaded 
vesicles, it is difficult to distinguish between the effects of 
ryanodine on Ca" uptake  and/or efflux. In  the present study, 
the permeability of the SR membrane to Ca" was more 
directly measured by using SR vesicles which were passively 
loaded with 45Ca2+ in  the absence of ATP. Evidence is pre- 
sented which suggests that heavy SR vesicles contain a Ca2+ 
release channel which can be activated or inhibited by ryano- 
dine, depending on the experimental conditions. A prelimi- 
nary account of part of this work has appeared (25). 
EXPERIMENTAL PROCEDURES 
Materials-Ryanodine, originally obtained from the S. P. Penick 
Corp.,  was the generous gift of Drs. Larry Jones  (Indiana University 
School of Medicine, Indianapolis, IN) and Joseph Feher (Medical 
College of Virginia, Richmond, VA). 45Ca2+  was purchased from ICN 
Pharmaceuticals, Irvine, CA, and  the  ATP analog AMP-PCP from 
Sigma.  All other reagents were of reagent grade. 
Isolation of Membranes-Heavy rabbit skeletal muscle SR Ca2+ 
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release  vesicle  fractions  were  recovered  from the 3645% region of a 
sucrose  gradient that contained  membranes sedimnting at 2,600- 
35,000 X g (13). The  "control"  vesicle  fraction  which  lacks the Ca2+ 
release  channel was recovered  from the 30-34% region of a sucrose 
gradient  containing  membranes  obtained by differential  pelleting at 
35,000-130,000 X g. 
Cardiac  muscle  SR  vesicles  were  isolated  from  approximately 100 
g of canine  ventricular  tissue.  Muscle (50 g) was  minced  and  homog- 
enized  in 350 ml of 0.3 M sucrose, 1 mM diisopropyl  fluorophosphate, 
a protease  inhibitor, and 20 mM K Pipes,  pH 7.4, at 4 "c for 60 s in 
a Waring  blender. The homogenate was centrifuged for 20 min at 
8,000 rpm (10,500 X g) in a GSA  rotor  in a Sorvall RC-2 centrifuge. 
A crude  microsomal  fraction was obtained  from the supernatant by 
centrifugation  for 60 min at 33,000 rpm (90,000 X g) in a Beckman 
type 35 rotor.  The  pellets were resuspended  in 0.3 M sucrose  contain- 
ing 0.4 M KC1,O.l mM MgClz, 100 pM EGTA, 100 pM Ca2+,  and 5 mM 
K Pipes,  pH 6.8, and  placed  in a Beckman Ti 14 zonal  rotor  on  top 
of a linear 20-45% (w/w) sucrose  gradient  containing 0.4 M KC1,O.l 
mM MgCl,, 100 p~ EGTA, 100 p~ Ca2+, and 5 mM K Pipes,  pH 6.8. 
After centrifugation for 180 min at 40,000 rpm, membranes sedi- 
menting between 19-25%, 25-28%, 28-31%, 31-33%, and 33-40% 
sucrose (as measured  with a refractometer at 22 "C) were  collected, 
diluted  with 1.5 volumes of 0.4 M KCI,  and  sedimented  by  centrifuga- 
tion  for 60 min at 33,000 rpm in a Beckman  type 35 rotor. The  pellets 
were  resuspended  in 0.3 M sucrose  and 5 mM K Pipes,  pH 6.8, quickly 
frozen,  and  stored at -135 "C. Among the five gradient  fractions, the 
31-40% sucrose  gradient  fractions  displayed the highest Ca2+ release 
activity. Between 4040% of the 45Ca2+ retained by the vesicles  in a 
medium containing 10 mM M$+ and 10 WM ruthenium was rapidly 
released  on  dilution into a medium containing 5 p M  free  Ca2+  (cf.  Fig. 
6). 
45Ca2+ Flux  Measurements  with  Passively Loaded Vesicles-"45Caz+ 
efflux rates from vesicles passively loaded with %az+ were deter- 
mined  by  Millipore filtration, as previously  described (10,13). Unless 
otherwise  indicated,  vesicles (5-10 mg of protein/ml) were  incubated 
at 22 "C in a loading  medium  containing  20 mM K Pipes,  pH 7, 0.1 
M KCI, 0.1 mM EGTA, and 0.2-5.1 mM &Ca2+. After 2 h, samples 
received an  addition of 0.1 volume  of  loading  medium  containing the 
dissolved  ryanodine,  followed by incubation  for  additional  times at 
22 and 37 "C. T a 2 +  efflux  behavior of the vesicles  was  assessed  by 
diluting vesicles into iso-osmolal unlabeled Caz+ release channel- 
inhibiting (10 mM M$+ plus 10 pM ruthenium  red) or Ca2+ release 
channel-activating (1 mM EGTA  plus 0.93 mM CaZ+; 5 p M  free Ca2+) 
media.  Untrapped  as  well as released %az+ was separated  away by 
placing the vesicles  on 0.45-pm HAWP  Millipore filters followed  by 
rapid rinsing to remove extravesicular 45Ca2+. 45Ca2+ radioactivity 
retained by the vesicles on the filters was determined by liquid 
scintillation  counting. 
45Ca2+ flux measurements were carried out at least in duplicate 
with two or more  time  points.  For a given preparation  the  standard 
errors were 210% or less. 
Biochemical  Assays-Protein  was  determined  by the Lowry method 
using  bovine  serum  albumin as a standard.  Free Ca2+ concentrations 
were adjusted  using the Caz+-chelating agent EGTA  and  were  calcu- 
lated  according  to a computer program using  binding  constants  pub- 
lished by Fabiato (26). 
RESULTS 
Measurement of 45Ca2+ Release from Passively Loaded Ves- 
icles-The presence of a Ca" release channel that could 
mediate the rapid release of intravesicular Ca2+ stores is 
shown in Fig. 1. Heavy SR Ca2+ release vesicles  were passively 
loaded with 1 mM 45Ca2+ and  then  either diluted  into a medium 
which inhibited or activated the Ca2+ release chmnel of SR. 
45Ca2+ efflux was  slow in Ca2+ release channel-inhibiting 
medium which contained 10 mM Mg+ and 1 0 ~ ~  ruthenium 
red. This allowed determination of the  amount of "Ca2+ (44 
nmol/mg of protein) that was trapped by all  intact vesicles 
(Fig. 1A). In contrast,  the vesicles released most of the 45Ca2+ 
within 30 s when diluted into  Ca2+ release channel-activating 
medium which contained 5 p~ free Ca2+. With the use of a 
rapid quench apparatus (13) it could be shown that 45Ca2+ was 
released with a first  order rate  constant of about 1 s-l (Fig. 
1B). The small  amount of &Ca2+ (6 nmol/mg of protein) that 
remained within the vesicles 30-60 s after dilution into  the 5 
p~ Ca" medium reflected a subpopulation of vesicles that 
lacked the Ca2+ release channel (10). 
The Effect of Ryanodine on 45Ca2+ Release-The effect of 
ryanodine on  the Ca2+ release behavior of heavy SR vesicles 
was determined by preincubating vesicles with or without 
ryanodine and by diluting them into media containing or 
lacking ryanodine. Dilution into Ca2+ release channel-inhib- 
iting media containing 0,1, or 150 p M  ryanodine gave similarly 
slow 45Ca2+ efflux rates  (not shown). 45Ca2+ efflux was also 
not appreciably affected when vesicles not pretreated with 
ryanodine were diluted into 5 p~ Ca2+ release media contain- 
ing 1 p~ ryanodine (Fig. 1B) while dilution of the vesicles 
into a release medium containing 150 p~ ryanodine increased 
the 45Ca2+ efflux rate about 1.5-fold. 
Prolonged incubation of the vesicles with ryanodine drast- 
ically altered their release behavior. Incubation with 1 p~ 
ryanodine for 20 min at 37 "C enhanced the amount of 45Ca2+ 
that was released by vesicles in  the Ca2+ release channel- 
inhibiting medium  (Fig. lA). Incubation with a high concen- 
tration of ryanodine (150 PM) had the opposite effect. In  this 
case, only a small fraction of the vesicle  45Ca2+  was released 
in channel-activating or -inhibiting media. Most of the  trap- 
ped 45Ca2+  was present in a releasable form since less than 1 
nmol of 45Ca2+/mg of protein was retained by the vesicles 
when the Ca2+ ionophore A23187 (2 pg/ml) was added to  the 
release media. 
Control experiments showed that ryanodine did not appre- 
ciably alter  the permeability of the Ca2+ release vesicles to 
[14C]sucrose. Further,  it was established that ryanodine did 
not change the Ca2+ permeability of control SR vesicles  which 
lack the Ca2+ Pelease channel. These results suggested a 
specific interaction of ryanodine with the Ca2+ release channel 
or a related  structure  in heavy SR vesicles. 
The time course of stimulation and inhibition of Ca2+ 
release by ryanodine was determined by preincubating heavy 
SR vesicles for varying times at 22 and 37 "C with 1 or 100 
pM ryanodine (Fig. 2A) .  Incubation with 1 pM ryanodlne at 
2 "C in  the presence of 1 mM Ca2+ caused the gradual release 
of 45Ca2+ in the Ca2+ release channel-inhibiting medium. 
Channel "opening,"  i.e. loss of 45Ca2+ from heavy SR vesicles, 
could be accelerated by either raising the incubation temper- 
ature to 37 "C or by increasing the ryanodine concentration 
to 100 pM. Prolonged incubation with 100 pM ryanodine at 
22 "C appeared to cause a gradual "closing" of the channel  in 
channel  inhibiting  and  activating media. This closing process 
was accelerated at 37 "C. 
The effectiveness of ryanodine in  stimulating  and  inhibiting 
45Ca2+ release from heavy SR vesicles  was dependent on the 
composition of the vesicle incubation media. Ac@tion of 5 
mM Mg2+ slowed the time course of ryanodine activation and 
inhibition of 45Ca2+ release (Fig. 2B). Other conditions that 
mtarded 45Ca2+ release activation and inhibition were the 
addition of 10 p~ ruthenium red or an increase in Ca2+ 
concentration to 10 mM, while lower Ca2+ concentrations 
rendered the vesicles  more sensitive to ryanodine. At 0.1 mM 
vesicles after incubation with 0.01 p~ ryanodine for 45 min 
at 37 "c (Fig. 3). Incubation with 100 PM ryanodine rendered 
most vesicles impermeable to 45Ca2+ in Ca2+ release channel- 
activating and -inhibiting media. Taken together, data of Figs. 
2 and 3 suggest that stimulation or inhibition of Ca2+ efflux 
was dependent  on ryanodine concentration,  temperature,  and 
time of incubation, as well as  external divalent cation concen- 
tration. 
A change in free Ca2+ or nucleotide concentration greatly 
45Ca2+ , rapid 45Ca2+ release occurred from most Ca2+ release 
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FIG. 1. Effect of ryanodine on 46Ca2+ efflux from skeletal muscle SR Ca" release vesicles. A, a heavy 
SR Ca2+ release vesicle fraction (5 mg  of protein/ml) was incubated for 2 h at 22 "C and 20 min at 37 "C with 1 
mM *Ca2+ in the presence of 0, 1, or 150 pM ryanodine (Ry). %a2+ efflux was initiated by diluting vesicles  20-fold 
into release media containing  either 10 mM Mg2+ plus 10 p M  ruthenium  red (RR, 0, A, W) or 1 mM EGTA plus 
0.88 mM Ca2+ (5 MM free Ca2+ after the addition of the vesicles) (0, A, 0). *Ca2+ efflux was terminated by placing 
vesicles on 0.45-pm Millipore filters followed by rapid rinsing with release medium to remove extravesicular 45Ca2+. 
Amounts of 45Ca2+ trapped by all intact vesicles in the incubation medium as well as amounts  not readily released 
in the 5 p~ Ca2+ release medium were obtained by back extrapolation to  the time of vesicle dilution. For vesicles 
not incubated with ryanodine, the amounts corresponded to 44 and 6 nmol/mg protein, respectively. B, an Update 
System 1000 chemical quench apparatus was used to determine the initial 45Ca2+ efflux rates in  the 5 p~ free Ca2+ 
release medium (13). Vesicles (2 mg of protein/ml) were incubated for 2  h at 22 "C with 1 mM 45Ca2+. %a2+ efflux 
was initiated by diluting vesicles with 4 volumes of release medium containing 6.25 mM EGTA, 5.55 mM Ca2+, and 
0 (0), 1.25 (O), or 187.5 p~ (A) ryanodine. Rapid 45Ca2+ efflux was inhibited at  the indicated times by the addition 
of 4  additional volumes of a quench solution containing 22.5 mM M$+ and 22.5 p~ ruthenium red.  Vesicles  were 
subsequently placed on 0.45-pm Millipore filters and rinsed with a medium containing  10 mM M$+ and 10 p~ 
ruthenium red. 
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FIG. 2. Time course of stimulation  and inhibition of 4sCa2+ release by ryanodine. A skeletal muscle SR 
Ca2+ release fraction (5 mg of protein/ml) was initially passively loaded with 1 mM 45Ca2+ (A) or 1 mM 45caz+ plus 
5 mM M$+ (B)  by incubation for 120 min at  22 "C.  Vesicles  were then incubated for the indicated times at  22 "C 
in the absence (0, 0) or presence of 1 (W, 0) or 100 PM (A, A) ryanodine (Ry). The 140-min time point was 
obtained  by  incubating vesicles in  the presence or absence of ryanodine for 120 min at 22 "C and 20 min at 37 "C. 
GCa2+ release was initiated by diluting vesicles  20-fold into release media containing  either 10 mM M$+ plus 10 
p~ ruthenium  red (0, W, A) or 5 mM EGTA plus 4.6 mM Ca2+ (0, 0, A). Amounts of &Ca2+ retained by the vesicles 
were obtained by back extrapolation to  the time of vesicle dilution (cf. Fig. L4). 
affects the Caz+ efflux rate from heavy SR vesicles (11, 13). 
The SR Ca2+ release channel rarely opens in  the absence of 
external Ca2+ and nucleotide. Micromolar concentrations of 
Ca2+ or millimolar concentrations of ATP by themselves 
partially  activate the channel by opening it for intermittent 
times. The presence of both Ca2+ and  ATP maximally stim- 
ulates Ca2+ release, and  the channel  is open essentially all the 
time. Millimolar Ca" in  the absence of nucleotide nearly fully 
inhibits the channel. In Fig. 4, vesicles were incubated at 
37 "C in  the presence or absence of 5 p~ ryanodine in media 
which partially opened (5  X M Ca2+ or lo-' M Ca2+ plus 
1 mM AMP-PCP) or nearly closed (lo-' M ca2+ or lod3 M 
Ca") the Ca2+ release channel of SR. 45Ca2+ influx was sub- 
sequently initiated at 23 "C in  a 1 mM 45Ca2+ medium and was 
stopped by the addition of 10 mM M P  and 10 PM ruthenium 
red. The amount of 45Ca2+ trapped by the vesicles  was deter- 
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FIG. 3. Dependence of 45Ca2+ efflux on ryanodine  concen- 
tration. A skeletal muscle SR Ca2+ release vesicle fraction (5 mg  of 
protein/ml) was incubated for 45 min at 37  "C with 0.1 mM free 45Ca2+ 
and  the indicated concentrations of ryanodine. Amounts of 4sCa2+ 
retained by the vesicles in  the 10 mM  M$+ 10 pM ruthenium red (RR, 
0) or 5 ~ L M  free Ca2+ (0) release media were determined as indicated 
in Fig. 1A. 
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FIG. 4. Effects of ryanodine on the Ca2+ permeability of 
skeletal muscle SR Ca" release vesicles incubated in the 
presence and absence of Ca" and AMP-PCP. Skeletal muscle 
SR Ca2+ release vesicles (5 mg  of protein/ml) were incubated in the 
presence of 5 p~ ryanodine at  37  "C for the indicated times. Incuba- 
tion media contained the indicated concentrations of free Ca2+ and 
AMP-PCP. Vesicles were subsequently diluted with 9 volumes of 
4sCa2' influx medium yielding a 45Ca2+ concentration of 1 mM and 
AMP-PCP concentration of  0.25  mM. 45Ca2+ influx was stopped at 15 
s by the addition of  25 volumes of a medium containing 10 mM Mg2f 
and 10 ~ L M  ruthenium red. Vesicles  were placed on 0.45-pm Millipore 
filters and rinsed with CaZ+ release channel-inhibiting medium. Data 
are expressed as  the percentage of &Ca2+ that was retained by vesicles 
incubated in the absence of ryanodine. 
mined by Millipore filtration. Vesicles not preincubated with 
ryanodine accumulated about 20 and 40 nmol/mg of protein 
when incubated with 1 mM 45Ca2+ for 15 s and 10 min, 
respectively. Preincubation of the vesicles with ryanodine 
reduced the  amounts of 45Ca2+ retained by the vesicles on the 
Millipore filters (Fig. 4). A reduction in vesicle 45Ca2+ sug- 
gested that,  as observed in  the 45Ca2+ efflux experiments, Mg2+ 
and ruthenium red were unable to block the release of accu- 
mulated 45Ca2+ on a time scale of 30-60 s. Ryanodine acted 
most rapidly in the two media containing either 5 x or 
IO-' Ca2+ plus 1 mM AMP-PCP.  Thus, it appeared that  an 
opening of the Ca2+ release channel favored its modification 
by ryanodine. 
Table I shows that ryanodine stimulated  and  inhibited  the 
TABLE I 
Effects of ryamdine  on &Ca+ release from skeletal muscle SR vesicles 
Skeletal muscle SR Ca2+ release vesicles  were incubated with 1 mM 
&Ca2+ for 90 min at  22 "C. After the addition of 0 or 150 p~ ryanodine, 
incubation was continued for 30 min at  22 "C or 30 min at  22 "C plus 
30 min at  37  "C. Release media contained  after addition of the vesicles 
the indicated concentrations of free Ca2+, M e ,  nucleotide, and 
ruthenium red (RR). The amounts of 45Ca2+ remaining with the 
vesicles at 30 s after dilution were determined by Millipore filtration. 
Vesicles retained 42 nmol of 45Ca2+/mg of protein when incubated for 
120 min at 22 "C in  the absence of ryanodine and diluted into  the 2 
X M Ca2+, 10 mM M$+, 10 p M  RR release medium. Data were 
normalized by setting this amount equal to 100%. 
T a Z +  in  SR vesicles 
30 min at 22 "C 
medium 30 min at 37 "C 
Composition of release 30 min at 22 "C plus 
-Ryano- +Ryano- "Ryano- +Ryano- 
dine dine dine dine 
2 X M CaZ+, 10 mM M e ,  
10 pM RR 
lo-' M Ca2+ 
10" M Ca2+, 5 mM ATP 
lo-' M Ca2+, 10 mM M$', 
10 pM RR 
5 X 1o"j M Caz+ 
5 X M Ca2+, 2.5 mM 
5 X lo4 M Ca2+, 10 mM 




lo-' M CaZ+ 
M La3+ 
% 
- 100 30 90 
70 30   
15 15 15 
97 38 90 
15  15  15 
13  14  13 
13 











release of 45Ca2+ under a variety of release conditions. In  the 
absence of ryanodine and at lo-' M Ca2+, 45Ca2+ efflux  was 
relatively slow. About one-third of the 45Ca2+ stores  in  the 
Ca2+ permeable vesicle population were released within 30 s, 
i.e. when the  first  time  point was taken using the Millipore 
filtration technique. Increase in free Ca2+ to 4 pM or the 
addition of 5 mM ATP or the addition of the nonhydrolyzable 
ATP analog AMP-PCP to the 5 p~ Ca2+ release medium 
yielded rate  constants of 45Ca2+ release ranging from about 1- 
100 s-l (13). Thus,  under  these conditions the Ca2+ permeable 
vesicle population completely released its 45Ca2+ stores within 
30 s. 45Ca2+ release was partially inhibited by adding 1 mM 
Mg2+ to  the 5 PM Ca2+ release medium and fully inhibited by 
10 mM ca2+ or 0.1 mM La3'. Prior exposure of the vesicles to 
150 I.IM ryanodine for 30 min at 22 "C resulted in  the rapid 
release of 45Ca2+ in  all release media. Specifically, ryanodine 
accelerated the release of vesicular 45Ca2+ at lo-' M. As ob- 
served in media containing Ca2+ in micromolar activating 
concentrations, Mg2+ and ruthenium red were unable to block 
45Ca2+ release at lo-' M Ca2+ on a time scale of 30 s. Two 
other  inhibitors of the  channel that were rendered ineffective 
by ryanodine were Las+ and high Caz+. 
Continued incubation of the vesicles with 150 I.IM ryanodine 
for 30 min at 37 "C inhibited the release of 45Ca2+ from about 
85% of the vesicles in all release media including those con- 
taining 5 p M  Ca and  the Ca2+-releasing drug caffeine (1-3) or 
AMP-PCP  (Table I). Under nearly optimally activating con- 
ditions (5  p M  free Ca2+ and 2.5 mM AMP-PCP), the first 
order rate  constant of 45Ca2+ release was  reduced  from 45 s-l 
to less than 0.01 s-* (not shown). 
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Effect of Ryanodine on ~-pH]Glucose Efflux-Both '%a2+ 
efflux and  ~-[~H]glucose efflux from heavy SR vesicles  were 
similarly influenced by the composition of the release media. 
Vesicles slowly released their ~-[~H]glucose contents when 
diluted into 10 mM Mg2+ or M free Ca2+ media (Fig. 5). 
About  half of the trapped ~-[~H]glucose was released within 
30 s when  vesicles  were diluted into a medium containing 5 
p~ free CaZ+ and 2.5 mM AMP-PCP. Rapid ~-[~H]glucose 
efflux, like that of 45Ca2+,  could be blocked  by the addition of 
10 mM Mg2+ or 10 p~ ruthenium red (not shown). Measure- 
ment of the initial release rate using the two blocking agents 
indicated that in the presence of 5 p~ free Caz+ and 2.5 mM 
AMP-PCP, L-glucose-permeable vesicles released ~- [~H]glu-  
cose with a first order rate constant of about 25 min-l. 
Omission of 2.5 mM AWP-PCP from the 5 pM Ca2+ release 
medium reduced the first order rate  constant  to  about 3 min-l. 
Under comparable conditions, the respective rate  constants 
of 45Ca2+ release were  45 and 1.2 s-l (not shown), Le. L-[~H] 
glucose  was released about 50 times slower than 45Ca2+. The 
glucose permeability of light vesicles which lack the Ca" 
release channel was not appreciably changed under the ex- 
perimental conditions of Fig.  5. It appeared, therefore, that 
L-glucose  was capable of passing, albeit slowly, through  the 
Ca2+- and nucleotide-activated Ca2+ release channel. 
Fig. 5 also shows the  ~-[~H]glucose efflux behavior of heavy 
SR vesicles which were preincubated with ryanodine, using 
conditions (20 p~ ryanodine for 120 min at  22 "c and 1 mM 
Ca2+) that rendered about 75% of the Ca" release vesicles 
permeable to 45Ca2+ in the Ca2+ release channel-inhibiting 
medium (not shown). In contrast to 45Caz+, ~-[~H]glucose 
efflux from ryanodine-treated vesicles  was fairly slow in media 
containing 10 mM M$+ (Fig. 5) or 10 p~ ruthenium red (not 
shown). It was, therefore, possible to determine the initial L- 
[3H]glucose efflux rates by Millipore filtration. Ryanodine 
had a moderate effect on  the L-glucose  efflux behavior of the 
vesicles. The efflux rate from L-glucose-permeable vesicles 
was increased by a factor of about 2 in media containing 
or 5 X M free Ca" (Fig. 5). On the other hand, ryanodine 
decreased the  rate  constant of L-glucose efflux from about 25 
I 
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skeletal -le SR Ca" release vesicles. A SR Caz+ release 
FIG. 5. Effect of ryanodine on ~-[~H]glucose efflux from 
vesicle fraction (10 mg  of protein/ml) was incubated for 2 h a t  22 "C 
in a medium containing 20 mM K Pipes, pH 7.0,O.l M KC1, 1 mM L- 
[3H]glucose, 0.1 mM EGTA, 1.1 mM Caz+, and either O (0, B, A, +) 
or 20 p~ ryanodine (0, 0, A, 0). ~-[~H]Glucose efflux was initiated 
by diluting vesicles 50-fold into iso-osmolal release media containing 
1 mM L-glucose and either 10 mM M e  (0, o), lo-' M free ca2+ (6, 
e), 5 X M free Ca2+ (B, O), or 5 X M free Ca2+ plus 2.5  mM 
AMP-PCP (A, A). The time course of ~-[~H]glucose efflux was 
obtained by measuring the amounts of ~-[~H]glucose  that remained 
with the vesicles a t  times ranging from 5 to 150 s. Five- and  10-s time 
points were determined by inhibiting ~-[~H]glucose efflux by the 
addition of 10 mM M$+ plus 10 p~ ruthenium red. 
to 10 min" when the Ca" release channel was nearly fully 
activated by diluting the vesicles into  the Ca2+- and nucleo- 
tide-containing medium. ~-[~H]Glucose efflux experiments 
suggest that  at low concentrations of ryanodine the  channel 
was not locked into a fully open configuration. 
Incubation of the vesicles with 100 p~ ryanodine under the 
conditions of Fig. 3 rendered most of the vesicles impermeable 
to  ~-[~H]glucose in media containing 10 mM M$+ plus 10 PM 
ruthenium red or 5 p~ Ca" plus 2.5 mM AMP-PCP. 
Effect of Ryanodine on 45Ca2+ Release from Cardiac  Muscle 
SR Vesicka-In  Fig. 6, cardiac muscle SR vesicles  were pas- 
sively loaded with 5 mM 45Ca2+ and diluted into media con- 
taining  either 10 mM Mg2+ plus 10 p~ ruthenium  red or 5 p~ 
free Ca2+. The vesicles retained 25 nmol of 45Ca2+/mg of 
protein when diluted into  the Ca" release-inhibiting medium. 
About 60% of this amount was released within 30 s in the 5 
p~ Ca2+ release medium. Thus, as in skeletal muscle (Fig. 
U), a subpopulation of cardiac muscle SR vesicles  was ca- 
pable of rapid %a2+ release. 
Incubation of the vesicles with 1 p~ ryanodine at 22 and 
37 "C caused the rapid release of 46Caz+ from about half of the 
Ca" permeable vesicles in  the Ca" release channel-inhibiting 
medium. At WO p ~ ,  ryanodine acted on most cardiac Ca2+ 
release vesicles after an incubation period of only 2 min at 
22 "C. Continued incubation with 100 p~ ryanodine at 22 and 
37 "C appeared to "close" the channel  in channel-inhibiting 
and -activating media. 
In contrast, the Ca2+ release behavior of skeletal muscle 
vesicles  was not appreciably affected by incubation with 1 p~ 
ryanodine in  the presence of 5 mM Ca2+ (not shown). Also, as 
observed in  the presence of 5 mM Mg+  (Fig. 2B), prolonged 
incubation at 22 "C with 100 p~ ryanodine was required to 
render skeletal muscle Ca2+ release vesicles permeable to 
45Ca2+ in  the  channel-inhibiting medium.  45Ca2+ release from 
skeletal muscle release vesicles  was not appreciably inhibited 
by 100 p~ ryanodine under the experimental conditions of 
Fig. 6. Thus, while ryanodine appeared to have a similar 
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FIG. 6. Effects of  ryanodine  on  46Ca2+ efflux from  cardiac 
muscle SR vesbles. A cardiac muscle SR vesicle fraction (5 mg of 
protein/ml) sedimenting at 31-33% sucrose (cj. "Experimental Pro- 
cedures") was passively loaded with 5 mM %az+ by incubation for 60 
22 "C with 0 (0, 01, 1 (B, U), or 100 p~ (A, A) ryanodine. The 35- 
min at 22 "C. Vesicles were then incubated for the indicated times at 
min time point was obtained by incubating vesicles in  the presence 
or absence of ryanodine for 20 min at 22 'C and 15 min at 37 "C. 
%a2+ release was initiated by diluting vesicles into release media 
containing 10 mM M$+ plus 10 p M  ruthenium red (0, B, A) or 5 pM 
free Ca2+ (0, 0, A). Amounts of %a2+ retained by the vesicles  were 
determined as indicated in Fig. 1A. 
overall effect on the  ea2+ release behavior of cardiac and 
skeletal muscle SR vesicles, in the presence of 5 mM Ca2+, 
ryanodine acted more  rapidly on cardiac than skeletal muscle 
SR Ca2+  release  vesicles. 
DISCUSSION 
A major  aim of the present study was to define conditions 
that would  allow ryanodine to "open" and "close" the Ca2+ 
release channel of SR. Stimulation or inhibition of Caz+  efflux 
was  influenced by the divalent cation concentration, temper- 
ature,  and time of incubation, plus the concentration of ry- 
anodine. At 37 "C and 0.1 mM Ca", essentially all skeletal 
muscle SR CaZ+ release  vesicles  were rendered permeable to 
45Ca2+ at a ryanodine concentration of 0.01 pM when  diluted 
into a  medium containing the two  Ca2+  release channel inhib- 
itors Mg2+ and ruthenium red. Inhibition of  45Ca2+ efflux  was 
observed  only at ryanodine concentrations in excess of 10 JAM. 
The apparent discrepancies in previous studies (18-24), 
where ryanodine stimulated or inhibited ATP-mediated Ca2+ 
uptake by skeletal and cardiac SR, can be resolved  by  consid- 
ering the difference in assay conditions and  the use of skeletal 
U ~ F S ' S U S  cardiac SR vesicles.  Some of the criteria of ryanodine 
action noted above  have  been  previously  recognized. Stimu- 
lation of T a 2 +  efflux by ryanodine from  actively  loaded  heavy 
or junctional terminal cisternae skeletal muscle SR vesicles 
was  blocked  by 5 mM Mg2+ (23) and ruthenium red (18). The 
effects of ryanodine  on  actively  loaded  cardiac  vesicles were 
dependent on ryanodine concentration and temperature (22). 
Pessah et al. (17) observed that specific [3H]ryan~dine binding 
was optimal at 70 JLM ea2+ for  heavy SR vesicle preparations 
from skeletal muscle and at 0.1-2 mM Ca" for  cardiac SR 
preparations. Lower and higher  Caz+  Concentrations as well 
as ruthenium red were inhibitory in both preparations, 
whereas M$+, Ba2+,  Cd2+, and La3+ inhibited 13H]ryanodine 
binding to  the skeletal preparation only. 
[3N]Ryanodine binding studies have  shown that heavy  skel- 
etal muscle SR preparations specifically bind about 10 pmol 
of ryanodine/mg of protein with  a KO of 20-200 nM (17,18). 
Cardiac preparations yielded nonlinear Scatchard plots indi- 
cating the presence of multiple  receptor sites (0.5 pmol/mg of 
protein, KD = 36 nM; and 1.7 pmolfmg protein, KO = 340 nM; 
Ref. 17). Comparison of the binding data with the dose- 
response  curves of  Fig. 3 suggests that ryanodine stimulated 
the release of Ca2+  from  heavy skeletal muscle SR vesicles  by 
binding to high affinity sites of the CaZ+ channel. 
The effectiveness of ryanodine appeared to be dependent 
on whether the Ca2' release channel was present in an open 
or  closed  configuration. Preincubation with  micromolar  Caz+ 
or 1 mM AMP-PCP in the presence of lo-' M Ca2+ partially 
opened the channel and resulted in rapid  modification of the 
channel by ryanodine (Fig. 4). Ryanodine acted less  readily 
at lo-* or M Ca2+, millimolar Mg", or micromolar ruthe- 
nium red, i.e. when 46Ca2+ release was slow. One possible 
explanation of these data is that ryanodine binds to a site 
which is accessible  only in  the open channel. Alternatively, 
ryanodine  might first diffuse across the membrane  before it 
binds to a site located on the inner surface of the vesicles. 
Diffusion of ryanodine may  be facilitated by the open channel 
since relatively  large  molecules such as L-glucose can traverse 
the open channel, 
The molecular  basis for the inhibitory action of ryanodine 
is unclear. Using ryanodine concentrations of 20-500 JLM, 
Feher and Lipford (ZZ} have  suggested that  the binding of 
ryanodine to  its cardiac receptor results in temporary activa- 
tion of a  Ca2+ channel which then slowly closes as it reaches 
a  more stable Configuration. An alternative exolanation is the 
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presence of a  minor ~ i b i t o r y  component in the ryanodine 
extracts isolated from Ryania speciosa. In support of this 
suggestion, inactivation of Ca2+ release was observed only 
when  ryanodine concentrations exceeded 10 PM (Fig. 3). 
The Ca2+ flux meas~ements of previous studies have not 
clarified to what extent the SR membrane  Ca2+  permeability 
is changed by ryanodine.  One  reason was that most  previous 
studies used the Ca2+-precipitating agent oxalate to increase 
the amounts of Ca2+  sequestered by the vesicles.  Changes in 
Ca2+  permeability  could, therefore, not be quantitated. Sec- 
ond, only  recently has it become evident that a  subpopulation 
of heavy terminal cisternae-derived skeletal muscle SR vesi- 
cles contains a  Ca2+-conducting channel which is regulated 
by external Ca", M e ,  and adenine nucleotides. Third, ry- 
anodine-induced Ca" efflux is rapid and could not be  effec- 
tively  blocked by inhibitors of the Ca2+  release  channel. The 
kinetics of ryanodine-induced '%a2+  efflux  could, therefore, 
not be studied with the use of the relatively slow Millipore 
filtration method  used in  this and the previous  vesicle  studies. 
The open SR Ca2+  release channel appears to form  a rather 
wide pore which can be traversed not only by Ca", but also 
by Baz+ (11), choline+ (27), and L-glucose (Fig. 5). L-[~H] 
Glucose  efflux  was  slow  enough  from ryanodine-treated vesi- 
cles to be  followed by Millipore fi~tration. This observation 
enabled us for the first  time to study the mechanism of action 
of ryanodine  which results in an increase in SR Ca" penne- 
ability. We found that  the rate of ~-[~H]glucose efflux  from 
vesicies treated and not treated with  ryanodine was regulated 
in a similar manner as 46Ca2+  efflux by external Caz+, M e ,  
and adenine nucleotide. At low concentrations, ryanodine 
appears, therefore, to affect the channel in a subtle way. Two 
possible modes of action are a  change in  the mechanism of 
channel activation and inactivation which is not readily de- 
tected using the slowly permeating molecule  L-glucose or a 
change in channel structure which prevents its complete 
closing. In order to distinguish these and other possible  mech- 
anisms, a shorter time  scale is required  for  measurements of 
Ca2+ fluxes with ryanodine. 
Recent results by Sutko's  laboratory2 support several as- 
pects of the present study. These investigators found  also that 
ryanodine  increased the Ca2+  permeability of passively  loaded 
junctional heavy skeletal muscIe SR vesicles  when present in 
0.01-10 JAM concentrations and decreased the Ca" permea- 
bility when present in concentrations greater than 10 JAM. 
['HIRyanodine-binding studies indicated that ryanodine  ex- 
erted its activating effect by binding to a  specific site (10-19 
pmol/mg of protein) with  a KO of 150-200 n u  Thus, recent 
studies by several laboratories suggest that ryanodine may  be 
a useful drug in identifying and characterizing the sarco- 
plasmic  reticulum Caz+ release channel components of skele- 
tal  and cardiac  muscle. 
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